<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><description>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 27 May 2021 11:26:24 +0800</pubDate><image><url>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</url><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>DEL洞察：成都先导-DNA编码化合物库平台赋能新药研发白皮书首发</title><link>https://mp.weixin.qq.com/s/hHw0TGB9ePcZGtOCBaizzw</link><description></description><content:encoded><![CDATA[DEL洞察：成都先导-DNA编码化合物库平台赋能新药研发白皮书首发]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>细胞疗法领军企业西比曼生物：将在ASCO公布新型CAR-T疗法最新临床数据</title><link>https://mp.weixin.qq.com/s/g6B0MTc3CMn2B0CWT4tedA</link><description></description><content:encoded><![CDATA[细胞疗法领军企业西比曼生物：将在ASCO公布新型CAR-T疗法最新临床数据]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>成都天台山制药-MAH委托加工与合作，邀您参加第三届CMC-China大会</title><link>https://mp.weixin.qq.com/s/iPzokBeG1klQvvaeMhfOow</link><description></description><content:encoded><![CDATA[成都天台山制药-MAH委托加工与合作，邀您参加第三届CMC-China大会]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/s-wDSLow6Sy7yOd1Vhi4nQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>【尾货处理】药企优质库存呆料低价处理，速来抢购！</title><link>https://mp.weixin.qq.com/s/EKN8wjsR-0jz-WUnBWw5ZQ</link><description></description><content:encoded><![CDATA[【尾货处理】药企优质库存呆料低价处理，速来抢购！]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/5re_0wncyBaan1S9hvEj3w</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>重磅！国知局：10亿级仑伐替尼制剂专利无效，继晶型后</title><link>https://mp.weixin.qq.com/s/_UlgkohN2PoW6QzUxbUlvw</link><description></description><content:encoded><![CDATA[重磅！国知局：10亿级仑伐替尼制剂专利无效，继晶型后]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>潜力药企：荣昌生物拟科创板上市，募资40亿</title><link>https://mp.weixin.qq.com/s/57c4_Z4H5tVd7_JLMx5oDQ</link><description></description><content:encoded><![CDATA[潜力药企：荣昌生物拟科创板上市，募资40亿]]></content:encoded><pubDate>Thu, 27 May 2021 09:11:04 +0800</pubDate></item><item><title>全球疫苗竞赛烽烟四起，新锐丽珠新冠疫苗临床进展显著</title><link>https://mp.weixin.qq.com/s/sgeI-QSTipvmpfh4-0l_ww</link><description></description><content:encoded><![CDATA[全球疫苗竞赛烽烟四起，新锐丽珠新冠疫苗临床进展显著]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>首届基石药业肿瘤精准治疗论坛  权威专家共议肿瘤精准治疗创新</title><link>https://mp.weixin.qq.com/s/zWfFysKhPicPmUPD2Mulfg</link><description></description><content:encoded><![CDATA[首届基石药业肿瘤精准治疗论坛  权威专家共议肿瘤精准治疗创新]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>“酶”好时代来临：数家药企角逐助力绿色制药</title><link>https://mp.weixin.qq.com/s/I1ylNU4bi0yLS3nGFcDn3A</link><description></description><content:encoded><![CDATA[“酶”好时代来临：数家药企角逐助力绿色制药]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>四川协力制药-特色原料药CDMO企业，邀您参加第三届CMC-China大会</title><link>https://mp.weixin.qq.com/s/Jm9BWfmfjj3NSGvvxyr-WQ</link><description></description><content:encoded><![CDATA[四川协力制药-特色原料药CDMO企业，邀您参加第三届CMC-China大会]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/n0P0eGIVtJZbMGM1iY_TmA</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/fpKOmcMD17KTgLoFKyafeA</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>阿达木单抗背后的技术：噬菌体展示技术</title><link>https://mp.weixin.qq.com/s/LLvDH9ovJlbipC7aVNJDRw</link><description></description><content:encoded><![CDATA[阿达木单抗背后的技术：噬菌体展示技术]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>License in模式大热，“云顶”奇迹背后的隐忧！</title><link>https://mp.weixin.qq.com/s/Ovoqhg2O5fsahD7nDzhaCg</link><description></description><content:encoded><![CDATA[License in模式大热，“云顶”奇迹背后的隐忧！]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>乘生物医药产业大势，这家大分子CDMO服务供应商在苏州快速成长</title><link>https://mp.weixin.qq.com/s/6xqSzTFbSCjbKmHLeMFt7g</link><description></description><content:encoded><![CDATA[乘生物医药产业大势，这家大分子CDMO服务供应商在苏州快速成长]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>晶泰智播｜晶型预测技术及多元化的应用</title><link>https://mp.weixin.qq.com/s/iFwkXseCYzwyjX_WVDoFcg</link><description></description><content:encoded><![CDATA[晶泰智播｜晶型预测技术及多元化的应用]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/j-tdx5g9-VwhWuj1tcOOKQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>重磅，小分子新锐同源康医药完成近4亿元人民币B+轮融资</title><link>https://mp.weixin.qq.com/s/G642Tk_h1Oo_hdWE0Ga0lA</link><description></description><content:encoded><![CDATA[重磅，小分子新锐同源康医药完成近4亿元人民币B+轮融资]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item></channel></rss>